LPL and hyperlipidemia: As the key inhibitors of LPL, the ANGPTL family members ANGPTL3 and ANGPTL4 interfere with LPL activity in different ways, leading to increased levels of TG, TC, and LDL and the development of hyperlipidemia [6].